| Year |
Citation |
Score |
| 2018 |
Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandiño G, Lawrenson K, Hazelett DJ, Najafabadi HS, Gjyshi A, Carvalho RS, Lyra PC, Coetzee SG, Shen HC, Yang AW, Earp MA, Yoder S, ... ... Coetzee GA, et al. Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus. Cancer Research. PMID 30487138 DOI: 10.1158/0008-5472.Can-17-3864 |
0.645 |
|
| 2018 |
Guo Y, Perez AA, Hazelett DJ, Coetzee GA, Rhie SK, Farnham PJ. CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops. Genome Biology. 19: 160. PMID 30296942 DOI: 10.1186/S13059-018-1531-0 |
0.723 |
|
| 2017 |
Feng Y, Rhie SK, Huo D, Ruiz-Narvaez EA, Haddad SA, Ambrosone CB, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, ... ... Coetzee G, et al. Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28377418 DOI: 10.1158/1055-9965.Epi-16-0567 |
0.706 |
|
| 2016 |
Rhie SK, Guo Y, Tak YG, Yao L, Shen H, Coetzee GA, Laird PW, Farnham PJ. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits. Epigenetics & Chromatin. 9: 50. PMID 27833659 DOI: 10.1186/S13072-016-0102-4 |
0.658 |
|
| 2016 |
Cai M, Kim S, Wang K, Farnham PJ, Coetzee GA, Lu W. 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus. Scientific Reports. 6: 22462. PMID 26934861 DOI: 10.1038/Srep22462 |
0.503 |
|
| 2016 |
Han Y, Rand KA, Hazelett DJ, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Schumacher FR, Berndt SI, Wang Z, Xu J, ... ... Coetzee GA, et al. Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. Journal of the National Cancer Institute. 108. PMID 26823525 DOI: 10.1093/Jnci/Djv431 |
0.493 |
|
| 2016 |
Hazelett DJ, Conti DV, Han Y, Al Olama AA, Easton D, Eeles RA, Kote-Jarai Z, Haiman CA, Coetzee GA. Reducing GWAS Complexity. Cell Cycle (Georgetown, Tex.). 15: 22-4. PMID 26771711 DOI: 10.1080/15384101.2015.1120928 |
0.369 |
|
| 2015 |
Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ, Crawford GE, Jaffe AE, Pinto D, Dracheva S, Geschwind DH, Mill J, Nairn AC, Abyzov A, Pochareddy S, Prabhakar S, ... ... Coetzee GA, et al. The PsychENCODE project. Nature Neuroscience. 18: 1707-1712. PMID 26605881 DOI: 10.1038/Nn.4156 |
0.309 |
|
| 2015 |
Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, ... ... Coetzee GA, et al. Corrigendum: Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nature Communications. 6: 8739. PMID 26498495 DOI: 10.1038/Ncomms9739 |
0.372 |
|
| 2015 |
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... ... Coetzee GA, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138 |
0.328 |
|
| 2015 |
Han Y, Hazelett DJ, Wiklund F, Schumacher FR, Stram DO, Berndt SI, Wang Z, Rand KA, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, ... ... Coetzee GA, et al. Integration of Multiethnic Fine-mapping and Genomic Annotation to Prioritize Candidate Functional SNPs at Prostate Cancer Susceptibility Regions. Human Molecular Genetics. PMID 26162851 DOI: 10.1093/Hmg/Ddv269 |
0.369 |
|
| 2015 |
Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, ... ... Coetzee GA, et al. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nature Communications. 6: 7138. PMID 26151821 DOI: 10.1038/Ncomms8138 |
0.383 |
|
| 2015 |
Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, ... ... Coetzee GA, et al. Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Human Molecular Genetics. PMID 26025378 DOI: 10.1093/Hmg/Ddv203 |
0.452 |
|
| 2015 |
Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, Rhie SK, Levanon K, Karst A, Drapkin R, Ramus SJ, Couch FJ, Offit K, Chenevix-Trench G, ... ... Coetzee GA, et al. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Human Molecular Genetics. 24: 3595-607. PMID 25804953 DOI: 10.1093/Hmg/Ddv101 |
0.76 |
|
| 2015 |
Patel N, Itakura T, Jeong S, Liao CP, Roy-Burman P, Zandi E, Groshen S, Pinski J, Coetzee GA, Gross ME, Fini ME. Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression. Plos One. 10: e0117758. PMID 25693195 DOI: 10.1371/Journal.Pone.0117758 |
0.485 |
|
| 2015 |
Coetzee S, Sabedot T, Silva TC, Coetzee G, Noushmehr H. Funci{SNP}: integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs biOMICs+: easily integrate public “OMICS” data for functional study F1000research. 4. DOI: 10.7490/F1000Research.1110817.1 |
0.325 |
|
| 2015 |
Han Y, Hazelett DJ, Henderson BE, Conti DV, Coetzee GA, Haiman CA. Abstract 4607: Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions Cancer Research. 75: 4607-4607. DOI: 10.1158/1538-7445.Am2015-4607 |
0.501 |
|
| 2015 |
Kote-Jarai Z, Olama AAA, Dadaev T, Hazelett D, Li Q, Leongamornlert D, Saunders E, Feedman M, Conti D, Easton D, Coetzee G, Eeles R. Abstract 4606: Fine mapping of 64 prostate cancer GWAS regions identifies multiple novel association signals Cancer Research. 75: 4606-4606. DOI: 10.1158/1538-7445.Am2015-4606 |
0.479 |
|
| 2014 |
Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, ... ... Coetzee GA, et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nature Genetics. 46: 1103-9. PMID 25217961 DOI: 10.1038/Ng.3094 |
0.508 |
|
| 2014 |
Rhie SK, Hazelett DJ, Coetzee SG, Yan C, Noushmehr H, Coetzee GA. Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells. Bmc Genomics. 15: 331. PMID 24885402 DOI: 10.1186/1471-2164-15-331 |
0.652 |
|
| 2014 |
Hazelett DJ, Rhie SK, Gaddis M, Yan C, Lakeland DL, Coetzee SG, Henderson BE, Noushmehr H, Cozen W, Kote-Jarai Z, Eeles RA, Easton DF, Haiman CA, ... ... Coetzee GA, et al. Comprehensive functional annotation of 77 prostate cancer risk loci. Plos Genetics. 10: e1004102. PMID 24497837 DOI: 10.1371/Journal.Pgen.1004102 |
0.741 |
|
| 2014 |
Biancolella M, Fortini BK, Tring S, Plummer SJ, Mendoza-Fandino GA, Hartiala J, Hitchler MJ, Yan C, Schumacher FR, Conti DV, Edlund CK, Noushmehr H, Coetzee SG, Bresalier RS, Ahnen DJ, ... ... Coetzee GA, et al. Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1. Human Molecular Genetics. 23: 2198-209. PMID 24256810 DOI: 10.1093/Hmg/Ddt584 |
0.395 |
|
| 2014 |
Shen HC, Coetzee S, Hazelett DJ, Coetzee GA, Noushmehr H, Gayther SA. Abstract 1380: Genome-wide fingerprinting of regulatory chromatin to evaluate the tissue specific origins of high-grade serous ovarian cancer Cancer Research. 74: 1380-1380. DOI: 10.1158/1538-7445.Am2014-1380 |
0.602 |
|
| 2013 |
Wei Z, Huang D, Gao F, Chang WH, An W, Coetzee GA, Wang K, Lu W. Biological implications and regulatory mechanisms of long-range chromosomal interactions. The Journal of Biological Chemistry. 288: 22369-77. PMID 23779110 DOI: 10.1074/Jbc.R113.485292 |
0.301 |
|
| 2013 |
Trotta AP, Need EF, Selth LA, Chopra S, Pinnock CB, Leach DA, Coetzee GA, Butler LM, Tilley WD, Buchanan G. Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation. International Journal of Cancer. Journal International Du Cancer. 133: 2812-23. PMID 23740762 DOI: 10.1002/Ijc.28310 |
0.488 |
|
| 2013 |
Rhie SK, Coetzee SG, Noushmehr H, Yan C, Kim JM, Haiman CA, Coetzee GA. Comprehensive functional annotation of seventy-one breast cancer risk Loci. Plos One. 8: e63925. PMID 23717510 DOI: 10.1371/Journal.Pone.0063925 |
0.703 |
|
| 2013 |
Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, Lange LA, Ng MC, Adeyemo AA, Allison MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, ... ... Coetzee GA, et al. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nature Genetics. 45: 690-6. PMID 23583978 DOI: 10.1038/Ng.2608 |
0.694 |
|
| 2013 |
Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, Orr N, Rhie SK, Riboli E, Feigelson HS, Le Marchand L, Buring JE, Eccles D, Miron P, Fasching PA, ... ... Coetzee GA, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature Genetics. 45: 392-8, 398e1-2. PMID 23535733 DOI: 10.1038/Ng.2561 |
0.718 |
|
| 2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Coetzee G, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.628 |
|
| 2013 |
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Coetzee GA, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 |
0.62 |
|
| 2013 |
Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, ... ... Coetzee GA, et al. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology. 144: 799-807.e24. PMID 23266556 DOI: 10.1053/J.Gastro.2012.12.020 |
0.419 |
|
| 2013 |
Hazelett DJ, Coetzee SG, Coetzee GA. A rare variant, which destroys a FoxA1 site at 8q24, is associated with prostate cancer risk. Cell Cycle (Georgetown, Tex.). 12: 379-80. PMID 23255135 DOI: 10.4161/Cc.23201 |
0.521 |
|
| 2013 |
Cozen W, Li D, Timofeeva M, Diepstra A, Hazelett D, Delahaye-Sourdeix M, Edlund CK, Rostgaard K, Berg DJVD, Franke L, Smedby KE, Glaser SL, Westra H, Robison LL, Mack TM, ... ... Coetzee G, et al. A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc Blood. 122: 626-626. DOI: 10.1182/Blood.V122.21.626.626 |
0.397 |
|
| 2012 |
Tewari AK, Yardimci GG, Shibata Y, Sheffield NC, Song L, Taylor BS, Georgiev SG, Coetzee GA, Ohler U, Furey TS, Crawford GE, Febbo PG. Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity. Genome Biology. 13: R88. PMID 23034120 DOI: 10.1186/Gb-2012-13-10-R88 |
0.437 |
|
| 2012 |
Siddiq A, Couch FJ, Chen GK, Lindström S, Eccles D, Millikan RC, Michailidou K, Stram DO, Beckmann L, Rhie SK, Ambrosone CB, Aittomäki K, Amiano P, Apicella C, ... ... Coetzee GA, et al. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Human Molecular Genetics. 21: 5373-84. PMID 22976474 DOI: 10.1093/Hmg/Dds381 |
0.722 |
|
| 2012 |
Trotta AP, Need EF, Butler LM, Selth LA, O'Loughlin MA, Coetzee GA, Tilley WD, Buchanan G. Subdomain structure of the co-chaperone SGTA and activity of its androgen receptor client. Journal of Molecular Endocrinology. 49: 57-68. PMID 22693264 DOI: 10.1530/Jme-11-0152 |
0.448 |
|
| 2012 |
Coetzee SG, Rhie SK, Berman BP, Coetzee GA, Noushmehr H. FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Research. 40: e139. PMID 22684628 DOI: 10.1093/Nar/Gks542 |
0.65 |
|
| 2012 |
Kerin T, Ramanathan A, Rivas K, Grepo N, Coetzee GA, Campbell DB. A noncoding RNA antisense to moesin at 5p14.1 in autism. Science Translational Medicine. 4: 128ra40. PMID 22491950 DOI: 10.1126/Scitranslmed.3003479 |
0.352 |
|
| 2012 |
Ting MC, Liao CP, Yan C, Jia L, Groshen S, Frenkel B, Roy-Burman P, Coetzee GA, Maxson R. An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice. Disease Models & Mechanisms. 5: 366-74. PMID 22279083 DOI: 10.1242/Dmm.008458 |
0.518 |
|
| 2012 |
Davis-Dao C, Koh CJ, Hardy BE, Chang A, Kim SS, De Filippo R, Hwang A, Pike MC, Carroll JD, Coetzee GA, Vandenberg D, Siegmund K, Cortessis VK. Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boys. The Journal of Clinical Endocrinology and Metabolism. 97: E393-9. PMID 22188741 DOI: 10.1210/Jc.2011-2439 |
0.415 |
|
| 2012 |
Little GH, Noushmehr H, Baniwal SK, Berman BP, Coetzee GA, Frenkel B. Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion. Nucleic Acids Research. 40: 3538-47. PMID 22187159 DOI: 10.1093/Nar/Gkr1219 |
0.454 |
|
| 2012 |
Coetzee GA. The usefulness of prostate cancer genome-wide association studies. The Journal of Urology. 187: 9-10. PMID 22088348 DOI: 10.1016/J.Juro.2011.10.057 |
0.461 |
|
| 2012 |
Tewari A, Yardimci G, Shibata Y, Sheffield N, Song L, Taylor B, Coetzee G, Furey T, Crawford G, Febbo P. Abstract A12: Chromatin accessibility reveals insight into androgen receptor activation and transcriptional specificity Cancer Research. 72: A12-A12. DOI: 10.1158/1538-7445.Prca2012-A12 |
0.371 |
|
| 2012 |
Noushmehr H, Coetzee SG, Rhie SK, Yan C, Haiman CA, Berman BP, Frenkel B, Coetzee GA. Abstract 1646: Integrative analysis identifies functional prostate cancer risk SNPs in genomic regulatory regions defined as enhancers Cancer Research. 72: 1646-1646. DOI: 10.1158/1538-7445.Am2012-1646 |
0.725 |
|
| 2012 |
Noushmehr H, Coetzee SG, Rhie SK, Yan C, Coetzee GA. The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers Androgen-Responsive Genes in Prostate Cancer: Regulation, Function and Clinical Applications. 59-84. DOI: 10.1007/978-1-4614-6182-1_5 |
0.709 |
|
| 2011 |
Noushmehr H, Coetzee GA. Identification and functional annotation of GWAS risk SNPs. Cell Cycle (Georgetown, Tex.). 10: 3995-6. PMID 22101276 DOI: 10.4161/Cc.10.23.18237 |
0.328 |
|
| 2011 |
Andreu-Vieyra C, Lai J, Berman BP, Frenkel B, Jia L, Jones PA, Coetzee GA. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells. Molecular and Cellular Biology. 31: 4648-62. PMID 21969603 DOI: 10.1128/Mcb.05934-11 |
0.479 |
|
| 2011 |
Buchanan G, Need EF, Barrett JM, Bianco-Miotto T, Thompson VC, Butler LM, Marshall VR, Tilley WD, Coetzee GA. Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells. Molecular and Cellular Endocrinology. 342: 20-31. PMID 21664238 DOI: 10.1016/J.Mce.2011.05.023 |
0.504 |
|
| 2011 |
Davis-Dao CA, Siegmund KD, Vandenberg DJ, Skinner EC, Coetzee GA, Thomas DC, Pike MC, Cortessis VK. Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types. Carcinogenesis. 32: 1238-43. PMID 21642359 DOI: 10.1093/Carcin/Bgr104 |
0.409 |
|
| 2011 |
Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, James M, Liu P, Tichelaar JW, Vikis HG, You M, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nature Genetics. 43: 513-8. PMID 21614091 DOI: 10.1038/Ng.840 |
0.471 |
|
| 2011 |
Jeong JH, Bhatia A, Toth Z, Oh S, Inn KS, Liao CP, Roy-Burman P, Melamed J, Coetzee GA, Jung JU. TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth. Plos One. 6: e16205. PMID 21267413 DOI: 10.1371/Journal.Pone.0016205 |
0.465 |
|
| 2011 |
Monteiro ANA, Coetzee GA, Freedman ML, Biasi MD, Casey G, Duggan D, Risch A, Plass C, Liu P, James M, Vikis HG, Tichelaar JW, You M, Gayther SA, Mills IG. Principles for the post-GWAS functional characterisation of risk loci Nature Precedings. 1-1. DOI: 10.1038/Npre.2010.5162.1 |
0.345 |
|
| 2010 |
Baniwal SK, Khalid O, Gabet Y, Shah RR, Purcell DJ, Mav D, Kohn-Gabet AE, Shi Y, Coetzee GA, Frenkel B. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis. Molecular Cancer. 9: 258. PMID 20863401 DOI: 10.1186/1476-4598-9-258 |
0.683 |
|
| 2010 |
Jiang X, Castelao JE, Yuan JM, Groshen S, Stern MC, Conti DV, Cortessis VK, Coetzee GA, Pike MC, Gago-Dominguez M. Hypertension, diuretics and antihypertensives in relation to bladder cancer. Carcinogenesis. 31: 1964-71. PMID 20732908 DOI: 10.1093/Carcin/Bgq173 |
0.34 |
|
| 2010 |
Berman BP, Frenkel B, Coetzee GA, Jia L. Androgen receptor responsive enhancers are flanked by consistently-positioned H3-acetylated nucleosomes. Cell Cycle (Georgetown, Tex.). 9: 2249-50. PMID 20495358 DOI: 10.4161/Cc.9.11.11621 |
0.428 |
|
| 2010 |
Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, Almendro V, He HH, Brown M, Liu XS, Davis M, Caswell JL, Beckwith CA, Hills A, Macconaill L, Coetzee GA, et al. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proceedings of the National Academy of Sciences of the United States of America. 107: 9742-6. PMID 20453196 DOI: 10.1073/Pnas.0910668107 |
0.45 |
|
| 2010 |
Frenkel B, Hong A, Baniwal SK, Coetzee GA, Ohlsson C, Khalid O, Gabet Y. Regulation of adult bone turnover by sex steroids. Journal of Cellular Physiology. 224: 305-10. PMID 20432458 DOI: 10.1002/Jcp.22159 |
0.598 |
|
| 2010 |
Coetzee GA, Jia L, Frenkel B, Henderson BE, Tanay A, Haiman CA, Freedman ML. A systematic approach to understand the functional consequences of non-protein coding risk regions. Cell Cycle (Georgetown, Tex.). 9: 256-9. PMID 20023379 DOI: 10.4161/Cc.9.2.10419 |
0.384 |
|
| 2010 |
Jiang X, Castelao JE, Yuan J, Groshen S, Stern MC, Conti DV, Cortessis VK, Coetzee GA, Pike MC, Gago-Dominguez M. Abstract 860: Hypertension, diuretics, and antihypertensives in relation to bladder cancer Cancer Research. 70: 860-860. DOI: 10.1158/1538-7445.Am10-860 |
0.337 |
|
| 2009 |
Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, Reich D, Yan C, Khalid O, Kantoff P, Oh W, Manak JR, Berman BP, Henderson BE, Frenkel B, Haiman CA, ... ... Coetzee GA, et al. Functional enhancers at the gene-poor 8q24 cancer-linked locus. Plos Genetics. 5: e1000597. PMID 19680443 DOI: 10.1371/Journal.Pgen.1000597 |
0.746 |
|
| 2009 |
Peters AA, Buchanan G, Ricciardelli C, Bianco-Miotto T, Centenera MM, Harris JM, Jindal S, Segara D, Jia L, Moore NL, Henshall SM, Birrell SN, Coetzee GA, Sutherland RL, Butler LM, et al. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Research. 69: 6131-40. PMID 19638585 DOI: 10.1158/0008-5472.Can-09-0452 |
0.412 |
|
| 2009 |
Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, Yao K, Kehoe SM, Lenz HJ, Haiman CA, Yan C, ... ... Coetzee GA, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nature Genetics. 41: 882-4. PMID 19561607 DOI: 10.1038/Ng.403 |
0.436 |
|
| 2009 |
Baniwal SK, Khalid O, Sir D, Buchanan G, Coetzee GA, Frenkel B. Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA. Molecular Endocrinology (Baltimore, Md.). 23: 1203-14. PMID 19389811 DOI: 10.1210/Me.2008-0470 |
0.712 |
|
| 2009 |
Jariwala U, Cogan JP, Jia L, Frenkel B, Coetzee GA. Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions. The Prostate. 69: 392-400. PMID 19058140 DOI: 10.1002/Pros.20893 |
0.502 |
|
| 2009 |
Jia L, Khalid O, Frenkel B, Coetzee GA. Chromatin remodeling and androgen receptor-mediated transcription Androgen Action in Prostate Cancer. 405-424. DOI: 10.1007/978-0-387-69179-4_18 |
0.65 |
|
| 2008 |
Jia L, Berman BP, Jariwala U, Yan X, Cogan JP, Walters A, Chen T, Buchanan G, Frenkel B, Coetzee GA. Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity. Plos One. 3: e3645. PMID 18997859 DOI: 10.1371/Journal.Pone.0003645 |
0.486 |
|
| 2008 |
Khalid O, Baniwal SK, Purcell DJ, Leclerc N, Gabet Y, Stallcup MR, Coetzee GA, Frenkel B. Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer. Endocrinology. 149: 5984-95. PMID 18755791 DOI: 10.1210/En.2008-0680 |
0.672 |
|
| 2008 |
Yuan JM, Chan KK, Coetzee GA, Castelao JE, Watson MA, Bell DA, Wang R, Yu MC. Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Carcinogenesis. 29: 1386-93. PMID 18544563 DOI: 10.1093/Carcin/Bgn136 |
0.403 |
|
| 2007 |
Buchanan G, Ricciardelli C, Harris JM, Prescott J, Yu ZC, Jia L, Butler LM, Marshall VR, Scher HI, Gerald WL, Coetzee GA, Tilley WD. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha. Cancer Research. 67: 10087-96. PMID 17942943 DOI: 10.1158/0008-5472.Can-07-1646 |
0.669 |
|
| 2007 |
Prescott J, Jariwala U, Jia L, Cogan JP, Barski A, Pregizer S, Shen HC, Arasheben A, Neilson JJ, Frenkel B, Coetzee GA. Androgen receptor-mediated repression of novel target genes. The Prostate. 67: 1371-83. PMID 17624924 DOI: 10.1002/Pros.20623 |
0.732 |
|
| 2007 |
Jariwala U, Prescott J, Jia L, Barski A, Pregizer S, Cogan JP, Arasheben A, Tilley WD, Scher HI, Gerald WL, Buchanan G, Coetzee GA, Frenkel B. Identification of novel androgen receptor target genes in prostate cancer. Molecular Cancer. 6: 39. PMID 17553165 DOI: 10.1186/1476-4598-6-39 |
0.656 |
|
| 2006 |
Cozen W, Gebregziabher M, Conti DV, Van Den Berg DJ, Coetzee GA, Wang SS, Rothman N, Bernstein L, Hartge P, Morhbacher A, Coetzee SG, Salam MT, Wang W, Zadnick J, Ingles SA. Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 2285-91. PMID 17119059 DOI: 10.1158/1055-9965.Epi-06-0446 |
0.382 |
|
| 2006 |
Jia L, Shen HC, Wantroba M, Khalid O, Liang G, Wang Q, Gentzschein E, Pinski JK, Stanczyk FZ, Jones PA, Coetzee GA. Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Molecular and Cellular Biology. 26: 7331-41. PMID 16980632 DOI: 10.1128/Mcb.00581-06 |
0.771 |
|
| 2006 |
Pitkänen-Arsiola T, Tillman JE, Gu G, Yuan J, Roberts RL, Wantroba M, Coetzee GA, Cookson MS, Kasper S. Androgen and anti-androgen treatment modulates androgen receptor activity and DJ-1 stability. The Prostate. 66: 1177-93. PMID 16652386 DOI: 10.1002/Pros.20450 |
0.447 |
|
| 2006 |
Prescott J, Coetzee GA. Molecular chaperones throughout the life cycle of the androgen receptor. Cancer Letters. 231: 12-9. PMID 16356826 DOI: 10.1016/J.Canlet.2004.12.037 |
0.652 |
|
| 2005 |
Jia L, Coetzee GA. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus. Cancer Research. 65: 8003-8. PMID 16140973 DOI: 10.1158/0008-5472.Can-04-3679 |
0.481 |
|
| 2005 |
Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocrine Reviews. 26: 898-915. PMID 16126938 DOI: 10.1210/Er.2003-0034 |
0.345 |
|
| 2005 |
Shen HC, Coetzee GA. The androgen receptor: unlocking the secrets of its unique transactivation domain. Vitamins and Hormones. 71: 301-19. PMID 16112272 DOI: 10.1016/S0083-6729(05)71010-4 |
0.607 |
|
| 2005 |
Shen HC, Buchanan G, Butler LM, Prescott J, Henderson M, Tilley WD, Coetzee GA. GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor. Biological Chemistry. 386: 69-74. PMID 15843149 DOI: 10.1515/Bc.2005.009 |
0.668 |
|
| 2005 |
Kim J, Jia L, Stallcup MR, Coetzee GA. The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus Journal of Molecular Endocrinology. 34: 107-118. PMID 15691881 DOI: 10.1677/Jme.1.01701 |
0.503 |
|
| 2005 |
Cozen W, Gebregziabher M, Vandenberg D, Conti D, Coetzee G, Bernstein L, Wang SS, Rothman N, Hartge P, Wang W, Coetzee S, Ingles SA. Interleukin-6 Promoter and Receptor Polymorphisms, Body Mass Index and Risk of Multiple Myeloma. Blood. 106: 5101-5101. DOI: 10.1182/Blood.V106.11.5101.5101 |
0.466 |
|
| 2004 |
Kim J, Coetzee GA. Prostate specific antigen gene regulation by androgen receptor. Journal of Cellular Biochemistry. 93: 233-41. PMID 15368351 DOI: 10.1002/Jcb.20228 |
0.504 |
|
| 2004 |
Buchanan G, Craft PS, Yang M, Cheong A, Prescott J, Jia L, Coetzee GA, Tilley WD. PC-3 cells with enhanced androgen receptor signaling: a model for clonal selection in prostate cancer. The Prostate. 60: 352-66. PMID 15264248 DOI: 10.1002/Pros.20079 |
0.644 |
|
| 2004 |
Buchanan G, Yang M, Cheong A, Harris JM, Irvine RA, Lambert PF, Moore NL, Raynor M, Neufing PJ, Coetzee GA, Tilley WD. Structural and functional consequences of glutamine tract variation in the androgen receptor. Human Molecular Genetics. 13: 1677-92. PMID 15198988 DOI: 10.1093/Hmg/Ddh181 |
0.759 |
|
| 2004 |
Castelao JE, Yuan JM, Gago-Dominguez M, Skipper PL, Tannenbaum SR, Chan KK, Watson MA, Bell DA, Coetzee GA, Ross RK, Yu MC. Carotenoids/vitamin C and smoking-related bladder cancer. International Journal of Cancer. Journal International Du Cancer. 110: 417-23. PMID 15095308 DOI: 10.1002/Ijc.20104 |
0.329 |
|
| 2004 |
Jia L, Choong CS, Ricciardelli C, Kim J, Tilley WD, Coetzee GA. Androgen receptor signaling: mechanism of interleukin-6 inhibition. Cancer Research. 64: 2619-26. PMID 15059919 DOI: 10.1158/0008-5472.Can-03-3486 |
0.41 |
|
| 2003 |
Kim J, Jia L, Tilley WD, Coetzee GA. Dynamic methylation of histone H3 at lysine 4 in transcriptional regulation by the androgen receptor. Nucleic Acids Research. 31: 6741-7. PMID 14627807 DOI: 10.1093/Nar/Gkg909 |
0.34 |
|
| 2003 |
Clark PE, Irvine RA, Coetzee GA. The androgen receptor CAG repeat and prostate cancer risk. Methods in Molecular Medicine. 81: 255-66. PMID 12725125 DOI: 10.1385/1-59259-372-0:255 |
0.761 |
|
| 2003 |
Gago-Dominguez M, Bell DA, Watson MA, Yuan JM, Castelao JE, Hein DW, Chan KK, Coetzee GA, Ross RK, Yu MC. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis. 24: 483-9. PMID 12663508 DOI: 10.1093/Carcin/24.3.483 |
0.371 |
|
| 2003 |
Jia L, Kim J, Shen H, Clark PE, Tilley WD, Coetzee GA. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms. Molecular Cancer Research : McR. 1: 385-92. PMID 12651911 |
0.607 |
|
| 2002 |
Coetzee G, Irvine R. Size of the androgen receptor CAG repeat and prostate cancer: does it matter? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 3572-3. PMID 12202654 DOI: 10.1200/Jco.2002.20.17.3572 |
0.751 |
|
| 2001 |
Buchanan G, Irvine RA, Coetzee GA, Tilley WD. Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Reviews. 20: 207-23. PMID 12085963 DOI: 10.1023/A:1015531326689 |
0.773 |
|
| 2001 |
Ingles SA, Wang J, Coetzee GA, Lee ER, Frankl HD, Haile RW. Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes & Control : Ccc. 12: 607-14. PMID 11552708 DOI: 10.1023/A:1011292002475 |
0.316 |
|
| 2001 |
Xue WM, Coetzee GA, Ross RK, Irvine R, Kolonel L, Henderson BE, Ingles SA. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort Cancer Epidemiology Biomarkers and Prevention. 10: 575-579. PMID 11401905 |
0.327 |
|
| 2000 |
Park JJ, Irvine RA, Buchanan G, Koh SS, Park JM, Tilley WD, Stallcup MR, Press MF, Coetzee GA. Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. Cancer Research. 60: 5946-9. PMID 11085509 |
0.747 |
|
| 2000 |
Xue W, Irvine RA, Yu MC, Ross RK, Coetzee GA, Ingles SA. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Research. 60: 839-41. PMID 10706090 |
0.759 |
|
| 2000 |
Ingles SA, Garcia DG, Wang W, Nieters A, Henderson BE, Kolonel LN, Haile RW, Coetzee GA. Vitamin D receptor genotype and breast cancer in Latinas (United States) Cancer Causes and Control. 11: 25-30. PMID 10680726 DOI: 10.1023/A:1008979417618 |
0.44 |
|
| 2000 |
Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Human Molecular Genetics. 9: 267-74. PMID 10607837 DOI: 10.1093/Hmg/9.2.267 |
0.756 |
|
| 2000 |
Ursin G, Ingles S, Spencer Feigelson H, Coetzee G, Bernstein L, Pike M, Buley A. Does a polymorphism in the CYP17 gene predict mammographic density? Breast Cancer Research. 2. DOI: 10.1186/Bcr171 |
0.427 |
|
| 1999 |
Ma H, Hong H, Huang SM, Irvine RA, Webb P, Kushner PJ, Coetzee GA, Stallcup MR. Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins. Molecular and Cellular Biology. 19: 6164-73. PMID 10454563 DOI: 10.1128/Mcb.19.9.6164 |
0.697 |
|
| 1999 |
Irvine RA, Coetzee GA. Additional upstream coding sequences of MAGE-11. Immunogenetics. 49: 585. PMID 10380710 DOI: 10.1007/S002510050543 |
0.649 |
|
| 1999 |
Ross RK, Coetzee GA, Pearce CL, Reichardt JK, Bretsky P, Kolonel LN, Henderson BE, Lander E, Altshuler D, Daley G. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. European Urology. 35: 355-61. PMID 10325489 DOI: 10.1159/000019909 |
0.499 |
|
| 1999 |
Durrin LK, Haile RW, Ingles SA, Coetzee GA. Vitamin D receptor 3'-untranslated region polymorphisms: Lack of effect on mRNA stability Biochimica Et Biophysica Acta - Molecular Basis of Disease. 1453: 311-320. PMID 10101249 DOI: 10.1016/S0925-4439(99)00007-1 |
0.422 |
|
| 1999 |
London SJ, Idle JR, Daly AK, Coetzee GA. Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet. 353: 898-9. PMID 10093988 DOI: 10.1016/S0140-6736(98)04984-8 |
0.31 |
|
| 1998 |
Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H, Stanczyk FZ, Kolonel LN, Henderson BE. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Research. 58: 4497-504. PMID 9788589 |
0.392 |
|
| 1998 |
Shirazi SK, Bober MA, Coetzee GA. Polymorphic exonic CAG microsatellites in the gene amplified in breast cancer (AIB1 gene) Clinical Genetics. 54: 102-103. PMID 9727751 DOI: 10.1111/J.1399-0004.1998.Tb03704.X |
0.378 |
|
| 1998 |
Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Sex steroid hormones and genetic susceptibility to breast and prostate cancer. Drug Metabolism Reviews. 30: 421-34. PMID 9606611 DOI: 10.3109/03602539808996320 |
0.336 |
|
| 1998 |
Ingles SA, Coetzee GA, Ross RK, Henderson BE, Kolonel LN, Crocitto L, Wang W, Haile RW. Association of prostate cancer with vitamin D receptor haplotypes in African-Americans Cancer Research. 58: 1620-1623. PMID 9563471 |
0.409 |
|
| 1997 |
Crocitto LE, Henderson BE, Coetzee GA. Identification of two germline point mutations in the 5'UTR of the androgen receptor gene in men with prostate cancer Journal of Urology. 158: 1599-1601. PMID 9302181 DOI: 10.1016/S0022-5347(01)64287-3 |
0.5 |
|
| 1997 |
Crocitto LE, Feigelson HS, Yu MC, Kolonel LN, Henderson BE, Coetzee GA. Short report on DNA marker at candidate locus. A polymorphism in intron 6 of the CYP17 gene Clinical Genetics. 52: 68-69. PMID 9272718 DOI: 10.1111/J.1399-0004.1997.Tb02519.X |
0.316 |
|
| 1997 |
Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. Journal of the National Cancer Institute. 89: 166-70. PMID 8998186 DOI: 10.1093/Jnci/89.2.166 |
0.779 |
|
| 1996 |
Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JKV, Henderson BE. Genetic susceptibility to cancer from exogenous and endogenous exposures Journal of Cellular Biochemistry. 63: 15-22. PMID 9027593 DOI: 10.1002/(Sici)1097-4644(1996)25+<15::Aid-Jcb2>3.0.Co;2-5 |
0.467 |
|
| 1995 |
Rubinsztein DC, Leggo J, Coetzee GA, Irvine RA, Buckley M, Ferguson-Smith MA. Sequence variation and size ranges of CAG repeats in the Machado-Joseph disease, spinocerebellar ataxia type 1 and androgen receptor genes. Human Molecular Genetics. 4: 1585-90. PMID 8541843 DOI: 10.1093/Hmg/4.9.1585 |
0.707 |
|
| 1995 |
Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Research. 55: 1937-40. PMID 7728763 |
0.749 |
|
| 1995 |
Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. Evidence of an x-linked or recessive genetic component to prostate cancer risk Nature Medicine. 1: 827-829. PMID 7585188 DOI: 10.1038/Nm0895-827 |
0.458 |
|
| 1995 |
Ross RK, Coetzee GA, Reichardt J, Skinner E, Henderson BE. Does the racial-ethnic variation in prostate cancer risk have a hormonal basis? Cancer. 75: 1778-1782. |
0.344 |
|
| 1994 |
Coetzee GA, Ross RK. Re: Prostate cancer and the androgen receptor Journal of the National Cancer Institute. 86: 872-873. PMID 8182772 DOI: 10.1093/Jnci/86.11.872 |
0.48 |
|
| 1992 |
Fourie AM, Coetzee GA, Gevers W, Van Der Westhuyzen DR. Low-density lipoprotein receptor point mutation results in expression of both active and inactive surface forms of the same mutant receptor Biochemistry®. 31: 12754-12759. PMID 1463746 DOI: 10.1021/Bi00166A007 |
0.33 |
|
| 1992 |
Coetzee GA, van der Westhuyzen DRV. Lipoprotein receptors in perspective Current Opinion in Lipidology. 3: 60-66. DOI: 10.1097/00041433-199204000-00002 |
0.319 |
|
| 1990 |
Rideout WM, Coetzee GA, Olumi AF, Jones PA. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes Science. 249: 1288-1290. PMID 1697983 DOI: 10.1126/Science.1697983 |
0.3 |
|
| 1984 |
Van der Westhuyzen DR, Coetzee GA, Demasius IPC. Low density lipoprotein receptor mutations in South African homozygous familial hypercholesterolemic patients Arteriosclerosis. 4: 238-247. PMID 6324732 DOI: 10.1161/01.Atv.4.3.238 |
0.324 |
|
| Show low-probability matches. |